Tofacitinib is associated with attainment of the minimally important reduction in axial magnetic resonance imaging inflammation in ankylosing spondylitis patients

Maksymowych, W.P.; Heijde, D. van der; Baraliakos, X.; Deodhar, A.; Sherlock, S.P.; Li, D.; ... ; Kanik, K.S. (2018)

Article / Letter to editor

• ankylosing spondylitis
• inflammation
• magnetic resonance imaging
• minimally important change
• sacroiliac joints
• spine
• SPondyloArthritis Research Consortium of Canada
• tofacitinib

• All authors: Maksymowych, W.P.; Heijde, D. van der; Baraliakos, X.; Deodhar, A.; Sherlock, S.P.; Li, D.; Fleishaker, D.; Hendrikx, T.; Kanik, K.S.
• Date: 2018-08-31
• Journal: Rheumatology
• Volume: 57
• Issue: 8
• Pages: 1390 - 1399
• DOI: doi:10.1093/rheumatology/key104
• Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055606/pdf/key104.pdf